-
Je něco špatně v tomto záznamu ?
Integrative pattern of vasomotor efficiency in SHR during ontogenesis
M. Gerová, F. Kristek
Jazyk angličtina Země Česko
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- Klíčová slova
- SHR, Ontogenesis, Noradrenaline, Acetylcholine, Vascular system,
- MeSH
- acetylcholin farmakologie MeSH
- financování organizované MeSH
- hypertenze patofyziologie MeSH
- krevní tlak účinky léků MeSH
- krysa rodu rattus MeSH
- modely nemocí na zvířatech MeSH
- noradrenalin farmakologie MeSH
- potkani inbrední SHR MeSH
- potkani Wistar MeSH
- stárnutí MeSH
- vazodilatancia farmakologie MeSH
- vazokonstriktory farmakologie MeSH
- vazomotorický systém patofyziologie růst a vývoj účinky léků MeSH
- věkové faktory MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
Numerous studies concerning the cardiovascular system in SHR often yield controversial data. The background of this diversity has various roots, ranging from different vascular segments or areas studied up to the different age of experimental animals. Our study aimed to follow the BP as an integrated response of vascular system. This approach was justified since stabilized cardiac output in SHR was proved till 1 year of age. The groups of male SHR (aged 3, 5, 9, 17 and 52 weeks) and age-matched Wistar rats were used. Significant basal BP difference between SHR and Wistar rats was found at 9 weeks of age and continued till the age of 52 weeks, reaching 189.6±11.9 mm Hg in SHR and 117.3±6.9 mm Hg in Wistar rats (P<0.01). The significant difference in BP increase to two doses of noradrenaline (0.1 µg and 1 µg) between SHR and control rats was also found at the age of 9 weeks. At 52 weeks the BP increment to two doses of noradrenaline was in SHR 19.7±2.0 mm Hg and 60.5±3.9 mm Hg and in Wistar rats 7.4±1.9 mm Hg and 40.5±3.2 mm Hg (P<0.01). The hypotensive response to acetylcholine (0.1 µg, 1 µg and 10 µg) in SHR was enhanced at 17 weeks of age only and this amplification persisted till the age of 52 weeks. In 52- week-old SHR the hypotensive response to three doses was 69.9±10.2 mm Hg, 87.5±11.8 mm Hg and 103.4±10.6 mm Hg, while in Wistar rats it was 37.4±4.2 mm Hg (P<0.01), 62.3±3.5 mm Hg (P<0.01) and 73.5±2.8 mm Hg (P<0.05). In conclusion, the efficiency of cardiovascular system of SHR to respond to noradrenaline was already enhanced from 9 weeks of age, whereas the response to acetylcholine was not augmented before the age of 17 weeks.
Citace poskytuje Crossref.org
Lit.: 41
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10015689
- 003
- CZ-PrNML
- 005
- 20111210180545.0
- 008
- 100726s2008 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.931318 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Gerová, Mária, $d 1926- $7 js20060616018
- 245 10
- $a Integrative pattern of vasomotor efficiency in SHR during ontogenesis / $c M. Gerová, F. Kristek
- 314 __
- $a Institute of Normal and Pathological Physiology, Centre of Excellence for Cardiovascular Research, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 504 __
- $a Lit.: 41
- 520 9_
- $a Numerous studies concerning the cardiovascular system in SHR often yield controversial data. The background of this diversity has various roots, ranging from different vascular segments or areas studied up to the different age of experimental animals. Our study aimed to follow the BP as an integrated response of vascular system. This approach was justified since stabilized cardiac output in SHR was proved till 1 year of age. The groups of male SHR (aged 3, 5, 9, 17 and 52 weeks) and age-matched Wistar rats were used. Significant basal BP difference between SHR and Wistar rats was found at 9 weeks of age and continued till the age of 52 weeks, reaching 189.6±11.9 mm Hg in SHR and 117.3±6.9 mm Hg in Wistar rats (P<0.01). The significant difference in BP increase to two doses of noradrenaline (0.1 µg and 1 µg) between SHR and control rats was also found at the age of 9 weeks. At 52 weeks the BP increment to two doses of noradrenaline was in SHR 19.7±2.0 mm Hg and 60.5±3.9 mm Hg and in Wistar rats 7.4±1.9 mm Hg and 40.5±3.2 mm Hg (P<0.01). The hypotensive response to acetylcholine (0.1 µg, 1 µg and 10 µg) in SHR was enhanced at 17 weeks of age only and this amplification persisted till the age of 52 weeks. In 52- week-old SHR the hypotensive response to three doses was 69.9±10.2 mm Hg, 87.5±11.8 mm Hg and 103.4±10.6 mm Hg, while in Wistar rats it was 37.4±4.2 mm Hg (P<0.01), 62.3±3.5 mm Hg (P<0.01) and 73.5±2.8 mm Hg (P<0.05). In conclusion, the efficiency of cardiovascular system of SHR to respond to noradrenaline was already enhanced from 9 weeks of age, whereas the response to acetylcholine was not augmented before the age of 17 weeks.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a acetylcholin $x farmakologie $7 D000109
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a stárnutí $7 D000375
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krevní tlak $x účinky léků $7 D001794
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a hypertenze $x patofyziologie $7 D006973
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a noradrenalin $x farmakologie $7 D009638
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a vazokonstriktory $x farmakologie $7 D014662
- 650 _2
- $a vazodilatancia $x farmakologie $7 D014665
- 650 _2
- $a vazomotorický systém $x patofyziologie $x růst a vývoj $x účinky léků $7 D014666
- 653 00
- $a SHR
- 653 00
- $a Ontogenesis
- 653 00
- $a Noradrenaline
- 653 00
- $a Acetylcholine
- 653 00
- $a Vascular system
- 700 1_
- $a Kristek, František. $7 xx0259762
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 57, č. 5 (2008), s. 677-684 $x 0862-8408
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/57/57_677.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 8
- 990 __
- $a 20100708110758 $b ABA008
- 991 __
- $a 20100810141318 $b ABA008
- 999 __
- $a ok $b bmc $g 756104 $s 619885
- BAS __
- $a 3
- BMC __
- $a 2008 $b 57 $c 5 $m Physiological research $x MED00003824 $d 677-684
- LZP __
- $a 2010-32/vtme